The results of the phase 3 MajesTEC-9 trial showcase teclistamab's efficacy for patients with relapsed/refractory multiple ...
After demonstrating significant improvement in progression-free survival, and now overall survival as well, the combination ...
By CH Unnikrsihnan Drug maker and researcher Glenmark Pharmaceuticals Ltd's new biological drug candidate Bi-Specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results